HEADER OXIDOREDUCTASE 26-JAN-07 2OOS TITLE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ENOYL ACP REDUCTASE WITH TITLE 2 TRICLOSAN REDUCTASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 GENE: FABI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON+-RIL CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PFENR, MALARIA, TRICLOSAN ANALOG, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR H.TSAI REVDAT 5 30-AUG-23 2OOS 1 REMARK SEQADV REVDAT 4 13-JUL-11 2OOS 1 VERSN REVDAT 3 24-FEB-09 2OOS 1 VERSN REVDAT 2 09-OCT-07 2OOS 1 JRNL REVDAT 1 17-JUL-07 2OOS 0 JRNL AUTH J.S.FREUNDLICH,F.WANG,H.-C.TSAI,M.KUO,H.-M.SHIEH, JRNL AUTH 2 J.W.ANDERSON,L.J.NKRUMAH,J.-C.VALDERRAMOS,M.YU,T.R.S.KUMAR, JRNL AUTH 3 S.G.VALDERRAMOS,W.R.JACOBS,G.A.SCHIEHSER,D.P.JACOBUS, JRNL AUTH 4 D.A.FIDOCK,J.C.SACCHETTINI JRNL TITL X-RAY STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL JRNL TITL 2 ACYL CARRIER PROTEIN REDUCTASE AS A PATHWAY TOWARD THE JRNL TITL 3 OPTIMIZATION OF TRICLOSAN ANTIMALARIAL EFFICACY JRNL REF J.BIOL.CHEM. V. 282 25436 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17567585 JRNL DOI 10.1074/JBC.M701813200 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 92.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 40686 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2160 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2960 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE SET COUNT : 164 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4492 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 136 REMARK 3 SOLVENT ATOMS : 177 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.57000 REMARK 3 B22 (A**2) : 0.57000 REMARK 3 B33 (A**2) : -1.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.194 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.167 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.105 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.816 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4721 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6386 ; 1.804 ; 1.998 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 564 ; 6.283 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 203 ;39.385 ;24.778 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 831 ;17.010 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;21.959 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 705 ; 0.159 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3492 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2236 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3244 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 235 ; 0.153 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 159 ; 0.276 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 45 ; 0.259 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2930 ; 1.181 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4545 ; 1.900 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2135 ; 2.844 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1841 ; 4.042 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2OOS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041400. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, XFIT REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42970 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: XFIT REMARK 200 STARTING MODEL: 1NHD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.35M (NH4)2SO4, 0.1M ACONA, PH 5.6, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.58150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 65.61050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 65.61050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.37225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 65.61050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 65.61050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.79075 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 65.61050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.61050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.37225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 65.61050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.61050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.79075 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.58150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 25190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 37720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -194.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 131.22100 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 131.22100 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.58150 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 88 REMARK 465 VAL A 89 REMARK 465 HIS A 90 REMARK 465 HIS A 91 REMARK 465 HIS A 92 REMARK 465 HIS A 93 REMARK 465 HIS A 94 REMARK 465 HIS A 95 REMARK 465 ASN A 96 REMARK 465 ASN A 324 REMARK 465 LYS A 325 REMARK 465 LEU A 326 REMARK 465 ASN A 327 REMARK 465 ASN A 328 REMARK 465 THR A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 ASN A 332 REMARK 465 ASN A 333 REMARK 465 THR A 334 REMARK 465 ASN A 335 REMARK 465 GLN A 336 REMARK 465 ASN A 337 REMARK 465 LYS A 338 REMARK 465 ASN A 339 REMARK 465 ARG A 340 REMARK 465 ASN A 341 REMARK 465 SER A 342 REMARK 465 HIS A 343 REMARK 465 ASP A 344 REMARK 465 VAL A 345 REMARK 465 HIS A 346 REMARK 465 ASN A 347 REMARK 465 ILE A 348 REMARK 465 MET A 349 REMARK 465 ASN A 350 REMARK 465 ASN A 351 REMARK 465 SER A 352 REMARK 465 GLY A 353 REMARK 465 GLU A 354 REMARK 465 LYS A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 LYS A 358 REMARK 465 LYS A 359 REMARK 465 ASN A 360 REMARK 465 SER A 361 REMARK 465 ALA A 362 REMARK 465 SER A 363 REMARK 465 GLN A 364 REMARK 465 ASN A 365 REMARK 465 TYR A 366 REMARK 465 MET B 88 REMARK 465 VAL B 89 REMARK 465 HIS B 90 REMARK 465 HIS B 91 REMARK 465 HIS B 92 REMARK 465 HIS B 93 REMARK 465 HIS B 94 REMARK 465 HIS B 95 REMARK 465 ASN B 96 REMARK 465 ASP B 154 REMARK 465 LYS B 155 REMARK 465 ASP B 156 REMARK 465 LYS B 157 REMARK 465 LYS B 325 REMARK 465 LEU B 326 REMARK 465 ASN B 327 REMARK 465 ASN B 328 REMARK 465 THR B 329 REMARK 465 TYR B 330 REMARK 465 GLU B 331 REMARK 465 ASN B 332 REMARK 465 ASN B 333 REMARK 465 THR B 334 REMARK 465 ASN B 335 REMARK 465 GLN B 336 REMARK 465 ASN B 337 REMARK 465 LYS B 338 REMARK 465 ASN B 339 REMARK 465 ARG B 340 REMARK 465 ASN B 341 REMARK 465 SER B 342 REMARK 465 HIS B 343 REMARK 465 ASP B 344 REMARK 465 VAL B 345 REMARK 465 HIS B 346 REMARK 465 ASN B 347 REMARK 465 ILE B 348 REMARK 465 MET B 349 REMARK 465 ASN B 350 REMARK 465 ASN B 351 REMARK 465 SER B 352 REMARK 465 GLY B 353 REMARK 465 GLU B 354 REMARK 465 LYS B 355 REMARK 465 GLU B 356 REMARK 465 GLU B 357 REMARK 465 LYS B 358 REMARK 465 LYS B 359 REMARK 465 ASN B 360 REMARK 465 SER B 361 REMARK 465 ALA B 362 REMARK 465 SER B 363 REMARK 465 GLN B 364 REMARK 465 ASN B 365 REMARK 465 TYR B 366 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 549 O HOH A 608 1.95 REMARK 500 O HOH B 516 O HOH B 676 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 238 CA - CB - CG ANGL. DEV. = -18.9 DEGREES REMARK 500 LEU A 248 CB - CG - CD2 ANGL. DEV. = 12.1 DEGREES REMARK 500 VAL A 273 CG1 - CB - CG2 ANGL. DEV. = 10.2 DEGREES REMARK 500 LEU B 238 CA - CB - CG ANGL. DEV. = -17.8 DEGREES REMARK 500 LEU B 248 CA - CB - CG ANGL. DEV. = 13.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 107 -175.75 -179.23 REMARK 500 ILE A 153 -60.79 -96.91 REMARK 500 ALA A 219 106.61 -164.29 REMARK 500 ASP A 414 21.17 -157.82 REMARK 500 PHE A 421 -80.27 -95.08 REMARK 500 ASP B 107 -173.53 178.86 REMARK 500 ASN B 160 72.24 -115.87 REMARK 500 ALA B 219 113.24 -164.07 REMARK 500 ASP B 414 23.06 -158.61 REMARK 500 ASN B 415 17.79 56.16 REMARK 500 PHE B 421 -70.24 -95.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JPJ A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JPJ B 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NHD RELATED DB: PDB REMARK 900 SAME PROTEIN WITHOUT BOUND INHIBITOR REMARK 900 RELATED ID: 1NHG RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN REMARK 900 RELATED ID: 1NHW RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1NNU RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1ZW1 RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1ZSN RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG DBREF 2OOS A 96 425 UNP Q9BH77 Q9BH77_PLAFA 96 425 DBREF 2OOS B 96 425 UNP Q9BH77 Q9BH77_PLAFA 96 425 SEQADV 2OOS MET A 88 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OOS VAL A 89 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OOS HIS A 90 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS A 91 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS A 92 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS A 93 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS A 94 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS A 95 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS MET B 88 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OOS VAL B 89 UNP Q9BH77 CLONING ARTIFACT SEQADV 2OOS HIS B 90 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS B 91 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS B 92 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS B 93 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS B 94 UNP Q9BH77 EXPRESSION TAG SEQADV 2OOS HIS B 95 UNP Q9BH77 EXPRESSION TAG SEQRES 1 A 338 MET VAL HIS HIS HIS HIS HIS HIS ASN GLU ASP ILE CYS SEQRES 2 A 338 PHE ILE ALA GLY ILE GLY ASP THR ASN GLY TYR GLY TRP SEQRES 3 A 338 GLY ILE ALA LYS GLU LEU SER LYS ARG ASN VAL LYS ILE SEQRES 4 A 338 ILE PHE GLY ILE TRP PRO PRO VAL TYR ASN ILE PHE MET SEQRES 5 A 338 LYS ASN TYR LYS ASN GLY LYS PHE ASP ASN ASP MET ILE SEQRES 6 A 338 ILE ASP LYS ASP LYS LYS MET ASN ILE LEU ASP MET LEU SEQRES 7 A 338 PRO PHE ASP ALA SER PHE ASP THR ALA ASN ASP ILE ASP SEQRES 8 A 338 GLU GLU THR LYS ASN ASN LYS ARG TYR ASN MET LEU GLN SEQRES 9 A 338 ASN TYR THR ILE GLU ASP VAL ALA ASN LEU ILE HIS GLN SEQRES 10 A 338 LYS TYR GLY LYS ILE ASN MET LEU VAL HIS SER LEU ALA SEQRES 11 A 338 ASN ALA LYS GLU VAL GLN LYS ASP LEU LEU ASN THR SER SEQRES 12 A 338 ARG LYS GLY TYR LEU ASP ALA LEU SER LYS SER SER TYR SEQRES 13 A 338 SER LEU ILE SER LEU CYS LYS TYR PHE VAL ASN ILE MET SEQRES 14 A 338 LYS PRO GLN SER SER ILE ILE SER LEU THR TYR HIS ALA SEQRES 15 A 338 SER GLN LYS VAL VAL PRO GLY TYR GLY GLY GLY MET SER SEQRES 16 A 338 SER ALA LYS ALA ALA LEU GLU SER ASP THR ARG VAL LEU SEQRES 17 A 338 ALA TYR HIS LEU GLY ARG ASN TYR ASN ILE ARG ILE ASN SEQRES 18 A 338 THR ILE SER ALA GLY PRO LEU LYS SER ARG ALA ALA THR SEQRES 19 A 338 ALA ILE ASN LYS LEU ASN ASN THR TYR GLU ASN ASN THR SEQRES 20 A 338 ASN GLN ASN LYS ASN ARG ASN SER HIS ASP VAL HIS ASN SEQRES 21 A 338 ILE MET ASN ASN SER GLY GLU LYS GLU GLU LYS LYS ASN SEQRES 22 A 338 SER ALA SER GLN ASN TYR THR PHE ILE ASP TYR ALA ILE SEQRES 23 A 338 GLU TYR SER GLU LYS TYR ALA PRO LEU ARG GLN LYS LEU SEQRES 24 A 338 LEU SER THR ASP ILE GLY SER VAL ALA SER PHE LEU LEU SEQRES 25 A 338 SER ARG GLU SER ARG ALA ILE THR GLY GLN THR ILE TYR SEQRES 26 A 338 VAL ASP ASN GLY LEU ASN ILE MET PHE LEU PRO ASP ASP SEQRES 1 B 338 MET VAL HIS HIS HIS HIS HIS HIS ASN GLU ASP ILE CYS SEQRES 2 B 338 PHE ILE ALA GLY ILE GLY ASP THR ASN GLY TYR GLY TRP SEQRES 3 B 338 GLY ILE ALA LYS GLU LEU SER LYS ARG ASN VAL LYS ILE SEQRES 4 B 338 ILE PHE GLY ILE TRP PRO PRO VAL TYR ASN ILE PHE MET SEQRES 5 B 338 LYS ASN TYR LYS ASN GLY LYS PHE ASP ASN ASP MET ILE SEQRES 6 B 338 ILE ASP LYS ASP LYS LYS MET ASN ILE LEU ASP MET LEU SEQRES 7 B 338 PRO PHE ASP ALA SER PHE ASP THR ALA ASN ASP ILE ASP SEQRES 8 B 338 GLU GLU THR LYS ASN ASN LYS ARG TYR ASN MET LEU GLN SEQRES 9 B 338 ASN TYR THR ILE GLU ASP VAL ALA ASN LEU ILE HIS GLN SEQRES 10 B 338 LYS TYR GLY LYS ILE ASN MET LEU VAL HIS SER LEU ALA SEQRES 11 B 338 ASN ALA LYS GLU VAL GLN LYS ASP LEU LEU ASN THR SER SEQRES 12 B 338 ARG LYS GLY TYR LEU ASP ALA LEU SER LYS SER SER TYR SEQRES 13 B 338 SER LEU ILE SER LEU CYS LYS TYR PHE VAL ASN ILE MET SEQRES 14 B 338 LYS PRO GLN SER SER ILE ILE SER LEU THR TYR HIS ALA SEQRES 15 B 338 SER GLN LYS VAL VAL PRO GLY TYR GLY GLY GLY MET SER SEQRES 16 B 338 SER ALA LYS ALA ALA LEU GLU SER ASP THR ARG VAL LEU SEQRES 17 B 338 ALA TYR HIS LEU GLY ARG ASN TYR ASN ILE ARG ILE ASN SEQRES 18 B 338 THR ILE SER ALA GLY PRO LEU LYS SER ARG ALA ALA THR SEQRES 19 B 338 ALA ILE ASN LYS LEU ASN ASN THR TYR GLU ASN ASN THR SEQRES 20 B 338 ASN GLN ASN LYS ASN ARG ASN SER HIS ASP VAL HIS ASN SEQRES 21 B 338 ILE MET ASN ASN SER GLY GLU LYS GLU GLU LYS LYS ASN SEQRES 22 B 338 SER ALA SER GLN ASN TYR THR PHE ILE ASP TYR ALA ILE SEQRES 23 B 338 GLU TYR SER GLU LYS TYR ALA PRO LEU ARG GLN LYS LEU SEQRES 24 B 338 LEU SER THR ASP ILE GLY SER VAL ALA SER PHE LEU LEU SEQRES 25 B 338 SER ARG GLU SER ARG ALA ILE THR GLY GLN THR ILE TYR SEQRES 26 B 338 VAL ASP ASN GLY LEU ASN ILE MET PHE LEU PRO ASP ASP HET NAD A 450 44 HET JPJ A 500 24 HET NAD B 450 44 HET JPJ B 500 24 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM JPJ 2-(2,4-DICHLOROPHENOXY)-5-(2-PHENYLETHYL)PHENOL FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 JPJ 2(C20 H16 CL2 O2) FORMUL 7 HOH *177(H2 O) HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 TRP A 131 ASN A 144 1 14 HELIX 3 3 THR A 173 ILE A 177 5 5 HELIX 4 4 ASP A 178 ASN A 184 1 7 HELIX 5 5 ASN A 184 MET A 189 1 6 HELIX 6 6 THR A 194 GLY A 207 1 14 HELIX 7 7 ASP A 225 THR A 229 5 5 HELIX 8 8 SER A 230 SER A 242 1 13 HELIX 9 9 SER A 242 VAL A 253 1 12 HELIX 10 10 TYR A 267 GLN A 271 5 5 HELIX 11 11 GLY A 280 ASN A 304 1 25 HELIX 12 12 SER A 317 ILE A 323 1 7 HELIX 13 13 THR A 367 ALA A 380 1 14 HELIX 14 14 LEU A 387 SER A 400 1 14 HELIX 15 15 ARG A 401 ARG A 404 5 4 HELIX 16 16 GLY A 416 MET A 420 5 5 HELIX 17 17 GLY B 110 ARG B 122 1 13 HELIX 18 18 TRP B 131 ASN B 144 1 14 HELIX 19 19 THR B 173 ILE B 177 5 5 HELIX 20 20 ASP B 178 ASN B 184 1 7 HELIX 21 21 THR B 194 GLY B 207 1 14 HELIX 22 22 ASP B 225 THR B 229 5 5 HELIX 23 23 SER B 230 SER B 242 1 13 HELIX 24 24 SER B 242 VAL B 253 1 12 HELIX 25 25 TYR B 267 GLN B 271 5 5 HELIX 26 26 GLY B 280 ASN B 304 1 25 HELIX 27 27 SER B 317 ALA B 322 1 6 HELIX 28 28 THR B 367 ALA B 380 1 14 HELIX 29 29 LEU B 387 SER B 400 1 14 HELIX 30 30 ARG B 401 ARG B 404 5 4 HELIX 31 31 GLY B 416 MET B 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N PHE A 128 O LEU A 165 SHEET 3 A 7 ILE A 99 ALA A 103 1 N ILE A 102 O ILE A 127 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N PHE A 101 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N THR A 266 SHEET 7 A 7 THR A 410 VAL A 413 1 O ILE A 411 N THR A 309 SHEET 1 B 7 ILE B 161 PRO B 166 0 SHEET 2 B 7 LYS B 125 ILE B 130 1 N ILE B 130 O LEU B 165 SHEET 3 B 7 ILE B 99 ALA B 103 1 N CYS B 100 O LYS B 125 SHEET 4 B 7 ILE B 209 HIS B 214 1 O VAL B 213 N PHE B 101 SHEET 5 B 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 B 7 ARG B 306 ALA B 312 1 O ILE B 310 N THR B 266 SHEET 7 B 7 THR B 410 VAL B 413 1 O VAL B 413 N SER B 311 SITE 1 AC1 28 ILE A 105 GLY A 106 GLY A 110 TYR A 111 SITE 2 AC1 28 TRP A 131 PHE A 167 ASP A 168 ALA A 169 SITE 3 AC1 28 SER A 215 LEU A 216 ALA A 217 ASN A 218 SITE 4 AC1 28 LEU A 265 THR A 266 LYS A 285 ALA A 312 SITE 5 AC1 28 GLY A 313 PRO A 314 LEU A 315 SER A 317 SITE 6 AC1 28 ALA A 319 JPJ A 500 HOH A 534 HOH A 541 SITE 7 AC1 28 HOH A 569 HOH A 637 HOH A 644 HOH A 687 SITE 1 AC2 28 GLY B 104 ILE B 105 GLY B 106 GLY B 110 SITE 2 AC2 28 TYR B 111 TRP B 131 PHE B 167 ASP B 168 SITE 3 AC2 28 ALA B 169 SER B 170 SER B 215 LEU B 216 SITE 4 AC2 28 ALA B 217 LEU B 265 THR B 266 LYS B 285 SITE 5 AC2 28 ALA B 312 GLY B 313 PRO B 314 LEU B 315 SITE 6 AC2 28 SER B 317 ALA B 319 JPJ B 500 HOH B 536 SITE 7 AC2 28 HOH B 568 HOH B 655 HOH B 656 HOH B 686 SITE 1 AC3 10 ALA A 217 ALA A 219 TYR A 267 VAL A 274 SITE 2 AC3 10 TYR A 277 ALA A 319 ILE A 323 PHE A 368 SITE 3 AC3 10 ILE A 369 NAD A 450 SITE 1 AC4 9 ALA B 217 ALA B 219 TYR B 267 TYR B 277 SITE 2 AC4 9 ALA B 319 ALA B 320 ILE B 323 PHE B 368 SITE 3 AC4 9 NAD B 450 CRYST1 131.221 131.221 83.163 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007621 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007621 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012025 0.00000